| Entity Name: | IMPEL PHARMACEUTICALS INC. |
| Jurisdiction: | FLORIDA |
| Filing Type: | Foreign Profit |
| Status: |
Inactive
The business entity is inactive. This status may signal operational issues or voluntary closure, raising concerns about the business's ability to repay loans and requiring careful risk assessment by lenders. |
| Date Filed: | 29 Jul 2021 (4 years ago) |
| Date of dissolution: | 27 Sep 2024 (7 months ago) |
| Last Event: | REVOKED FOR ANNUAL REPORT |
| Event Date Filed: | 27 Sep 2024 (7 months ago) |
| Document Number: | F21000004291 |
| FEI/EIN Number |
26-3058238
Federal Employer Identification (FEI) Number assigned by the IRS. |
| Address: | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119, US |
| Mail Address: | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119, US |
| Place of Formation: | DELAWARE |
| Name | Role | Address |
|---|---|---|
| ADAMS ADRIAN | Director | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119 |
| PARKER STEWART | Director | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119 |
| SHAH MAHENDRA | Director | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119 |
| Allison David | Director | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119 |
| Leaman John | Director | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119 |
| Leman, MD John | Chief Financial Officer | 201 ELLIOTT AVENUE W., STE 260, SEATTLE, WA, 98119 |
| Event Type | Filed Date | Value | Description |
|---|---|---|---|
| REVOKED FOR ANNUAL REPORT | 2024-09-27 | - | - |
| NAME CHANGE AMENDMENT | 2022-08-03 | IMPEL PHARMACEUTICALS INC. | - |
| Name | Date |
|---|---|
| Reg. Agent Resignation | 2024-07-03 |
| ANNUAL REPORT | 2023-02-28 |
| Name Change | 2022-09-13 |
| ANNUAL REPORT | 2022-04-22 |
| Foreign Profit | 2021-07-29 |
Date of last update: 01 Apr 2025
Sources: Florida Department of State
